ADXS — Ayala Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $24.30m
- $27.23m
- $0.01m
Advaxis Inc reports results for the quarter ended in July - Earnings Summary
Advaxis Inc :A loss of 4 cents per share anticipated for third quarter
Advaxis Inc expected to post a loss of 4 cents a share - Earnings Preview
Advaxis Inc expected to post a loss of 4 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Didi, Forte Biosciences, Future Fintech, MongoDB
Brief: Advaxis Says Nasdaq Granted Extension To Regain Compliance With Minimum Bid Price Rule
Advaxis rises after starting human trials of prostate cancer drug
Brief: Advaxis Announces Initiation Of Phase 1 Clinical Trial Of ADXS-504 For Treatment Of Early Prostate Cancer
U.S. STOCKS ON THE MOVE-Didi Global, Amazon.com, Tesla, Provention Bio
U.S. STOCKS ON THE MOVE-Weibo, Tesla, Didi Global, Amazon.com
U.S. STOCKS ON THE MOVE-Weibo, Didi Global, Advaxis, Amazon.com
Refinitiv Newscasts - U.S. Morning Call: Wall Street eyes cautious open after long holiday weekend, Didi, OPEC+, Amazon
Advaxis jumps on merger with Biosight
Brief: Advaxis And Biosight Announce Entry Into Definitive Merger Agreement
Brief: Advaxis Says Nasdaq Notified Co Had Not Regained Compliance With Listing Rule
Brief: Advaxis Reports Second Quarter Financial Results And Provides A Business Update
Advaxis Inc reports results for the quarter ended in April - Earnings Summary
U.S. STOCKS ON THE MOVE-Virgin Galactic, Kohl's, Ralph Lauren, Tesla
U.S. STOCKS ON THE MOVE-Tesla, VBI Vaccines, Ralph Lauren, Virgin Galactic